Daizadeh, Nadia S.
92  Ergebnisse:
Personensuche X
?
1

Safety Observations With 3 Years of Denosumab Exposure: Com..:

Watts, Nelson B ; Brown, Jacques P ; Papapoulos, Socrates...
Journal of Bone and Mineral Research.  32 (2017)  7 - p. 1481-1485 , 2017
 
?
3

The Effect of Three or Six Years of Denosumab Exposure in W..:

Bone, Henry G. ; Chapurlat, Roland ; Brandi, Maria-Luisa...
The Journal of Clinical Endocrinology & Metabolism.  98 (2013)  11 - p. 4483-4492 , 2013
 
?
 
?
5

Influence of subject discontinuation on long-term nonverteb..:

Adachi, Jonathan D ; Bone, Henry G ; Daizadeh, Nadia S...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s12891-017-1520-6.  , 2017
 
?
7

Efficacy and safety of alemtuzumab over 6 years: final resu..:

Coles, Alasdair J. ; Arnold, Douglas L. ; Bass, Ann D....
Therapeutic Advances in Neurological Disorders.  14 (2021)  - p. 175628642098213 , 2021
 
?
8

Conjunctivitis in Dupilumab Clinical Trials for Adolescents..:

Bansal, Ashish ; Simpson, Eric L. ; Paller, Amy S....
American Journal of Clinical Dermatology.  22 (2021)  1 - p. 101-115 , 2021
 
?
9

Proportion of alemtuzumab-treated patients converting from ..:

Horáková, Dana ; Boster, Aaron ; Bertolotto, Antonio...
Multiple Sclerosis Journal - Experimental, Translational and Clinical.  6 (2020)  4 - p. 205521732097213 , 2020
 
?
 
?
12

Infection risk with alemtuzumab decreases over time: pooled..:

Wray, Sibyl ; Havrdova, Eva ; Snydman, David R...
Multiple Sclerosis Journal.  25 (2018)  12 - p. 1605-1617 , 2018
 
?
 
?
 
1-15